CD4 and COVID-19: This study has revealed that those only those convalescent COVID-19 patients who had readily detectable RBD-specific CD4 T cell in vitro recall responses had significantly higher neutralizing antibody titres, whereas lower anti-spike antibody levels, especially neutralizing antibody titres, were associated with a lack of RBD-specific proliferative CD4 T cells.